Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Summary by 6ix AI

Goldline Pharmaceutical Ltd. has filed a disclosure regarding the acquisition of shares under SEBI regulations. The filing states that Mr. Prashant Shrikishna Karkare, an Executive Director, acquired shares from the open market. The acquisition involved a specific number of equity shares, representing a small percentage of the company's total issued capital. The company requests that this disclosure be recorded by the BSE.

Written by 6ix AI from the company’s filing. How 6ix writes summaries